BRPI0910998A2 - composição para tratamento de acne e método para tratar acne - Google Patents

composição para tratamento de acne e método para tratar acne

Info

Publication number
BRPI0910998A2
BRPI0910998A2 BRPI0910998A BRPI0910998A BRPI0910998A2 BR PI0910998 A2 BRPI0910998 A2 BR PI0910998A2 BR PI0910998 A BRPI0910998 A BR PI0910998A BR PI0910998 A BRPI0910998 A BR PI0910998A BR PI0910998 A2 BRPI0910998 A2 BR PI0910998A2
Authority
BR
Brazil
Prior art keywords
acne
treatment composition
treating
treating acne
acne treatment
Prior art date
Application number
BRPI0910998A
Other languages
English (en)
Inventor
Georgia Levis
Original Assignee
Georgia Levis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgia Levis filed Critical Georgia Levis
Publication of BRPI0910998A2 publication Critical patent/BRPI0910998A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0910998A 2008-07-17 2009-07-17 composição para tratamento de acne e método para tratar acne BRPI0910998A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8141708P 2008-07-17 2008-07-17
PCT/US2009/050941 WO2010009369A2 (en) 2008-07-17 2009-07-17 Methods and materials for the treatment of acne

Publications (1)

Publication Number Publication Date
BRPI0910998A2 true BRPI0910998A2 (pt) 2016-01-19

Family

ID=41530487

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910998A BRPI0910998A2 (pt) 2008-07-17 2009-07-17 composição para tratamento de acne e método para tratar acne

Country Status (6)

Country Link
US (1) US20100015216A1 (pt)
EP (1) EP2318011A4 (pt)
JP (1) JP2011528377A (pt)
CN (1) CN102159216A (pt)
BR (1) BRPI0910998A2 (pt)
WO (1) WO2010009369A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012053014A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
US10028972B2 (en) 2010-10-21 2018-07-24 Cadila Healthcare Limited Pharmaceutical compositions of anti-acne agents
WO2012053010A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin
WO2013054809A1 (ja) * 2011-10-14 2013-04-18 大正製薬株式会社 皮膚外用剤
WO2016205089A1 (en) 2015-06-17 2016-12-22 Profet Margaret Jean Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN112353789B (zh) * 2015-12-25 2022-05-17 北京乳凝创智生物技术研发中心（有限合伙） 一种化妆品
CN106420787B (zh) * 2016-08-26 2020-05-26 陈启红 一种痤疮膏及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957983A (en) * 1975-03-12 1976-05-18 Intellectual Property Development Corporation Prevention of toxicity accompanying administration of 3,7-disubstituted bile acids
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
FR2726468B1 (fr) * 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
WO1996019211A1 (en) * 1994-12-19 1996-06-27 Taisho Pharmaceutical Co., Ltd. Liposome eye drops
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
JP4070935B2 (ja) * 2000-03-31 2008-04-02 株式会社コーセー にきび用皮膚外用剤
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
BR0214993A (pt) * 2001-12-07 2004-12-07 Johnson & Johnson Consumer Processo para redução de acne ou aperfeiçoamento de tÈnus de pele
ATE354380T1 (de) * 2003-02-03 2007-03-15 Polaschegg Hans-Dietrich Dr Te Zusammensetzung zur prävention von infektionen durch subkutane prothesen
US20040214891A1 (en) * 2003-04-22 2004-10-28 Janusz Marcinkiewicz Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition
US20050008684A1 (en) * 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
DE102005031705A1 (de) * 2005-07-05 2007-01-18 Henkel Kgaa Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
JP5061984B2 (ja) * 2007-03-31 2012-10-31 大正製薬株式会社 アダパレン含有外用剤組成物

Also Published As

Publication number Publication date
JP2011528377A (ja) 2011-11-17
WO2010009369A3 (en) 2010-04-01
EP2318011A4 (en) 2011-09-14
CN102159216A (zh) 2011-08-17
WO2010009369A2 (en) 2010-01-21
EP2318011A2 (en) 2011-05-11
US20100015216A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
PT2250275T (pt) Aparelho e método para tratar resíduos
BRPI0911735A2 (pt) aparelho e método para o tratamento de água de lastro
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0815283A2 (pt) Equipamento para o tratamento da biomassa, método para o tratamento da biomassa, biomassa tratada e hidrolisado
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
BR112012028514A2 (pt) composição para o tratamento da água residual e processo para o tratamento de água residual
PT2340042E (pt) Métodos e composições para o tratamento de cancro
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0812585A2 (pt) Aparelho de tratamento de redução e método de tratamento de redução
BRPI0810806A2 (pt) Método para tratar uma lesão cutânea em um indivíduo
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0912337A2 (pt) composto método para melhorar memória em paciente, e, método para tratar condições
BRPI0908854A2 (pt) composições e métodos para o tratamento de tumor de origem hematopoética
PT2170055T (pt) Composição para utilização no tratamento de lesão do tecido conjuntivo
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BRPI1013878A2 (pt) método para tratar distúrbios metabólicos, e, composto
BRPI0923534A2 (pt) composição e método para tratamento de doenças de pele
BRPI0913280A2 (pt) dispositivo e método para o tratamento de fluxos de artigos
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI0911098A2 (pt) formulação lipossomal e método para tratamento de bexiga hiperativa.
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0909144A8 (pt) processo para o tratamento de água de descarga e instalação de tratamento de água de descarga
FI20070935L (fi) Koostumus ja menetelmä puun käsittelemiseksi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.